Press Releases

 
Press Releases
  Date Title View
Jul 21, 2015
LYON, France, July 21, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it has received a letter from the U.S. Food and Drug Administration ("FDA") related to its Direct De Novo 510(k) petition for Ablatherm HIFU in the United States. The "Deficiency List" (as such communications ...
Jul 14, 2015
LYON, France, July 14, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that François Dietsch, currently Group Financial Control Manager and Finance Manager of the Company's French subsidiary, has been promoted to the position of Chief Financial Officer, effective immediately. ...
Jul 7, 2015
LYON, France, July 7, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the adoption of its Focal One system under a pay-per-procedure sale contract by two major University hospitals in Switzerland: the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne and Geneva University Ho...
Jul 2, 2015
LYON, France, July 2, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Eric Soyer, Chief Financial Officer, has resigned from the Company to accept a top management position at a publicly traded biotechnology company. To ensure a smooth transition, Mr. Soyer will remain with the C...
Jun 9, 2015
LYON, France, June 9, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the installation of a Focal One system under a Revenue-per-procedure ("RPP") contract with the Martini-Klinik at the University Hospital Hamburg-Eppendorf (UKE) in Germany. The Martini-Klinik is the world's ...
May 12, 2015
1Q 2015 and Recent Operational Highlights Direct De Novo petition for Ablatherm HIFU submitted to the FDA in April 2015; Treatment-driven revenue from the HIFU division increased 17% year-over-year; Revenue for first quarter 2015 totaled EUR 6.2 million (USD 6.9 million); Canadian regulatory approval of F...
May 6, 2015
LYON, France, May 6, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the first quarter ended March 31, 2015 on Tuesday, May 12, 2015, after the close of trading. Company management will host a conference call on Wednesday, May 13,...
Apr 1, 2015
2014 and Recent Operational Highlights Record revenue in 2014 of EUR 26.8 million (USD 35.4 million); 11% growth over the previous year; Full-year HIFU revenue increased 70% over 2013; Strong Cash position of EUR 12.1 million (USD 14.7 million) as of December 31, 2014; Filing Direct De Novo petition for A...
Mar 31, 2015
LYON, France, March 31, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first sale of Focal One HIFU device to Jewish General Hospital, Montreal, Canada. This sale occurs only two months after the Company gained Health Canada's approval to market its Focal One HIFU device for foca...
Mar 26, 2015
LYON, France, March 26, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the Company's participation in a major collaborative liver cancer project aimed at developing innovative new therapies for this prevalent indication. "HECAM" (HEpatocellular CArcinoma Multi-technological) ...
1
... NextLast
= add release to Briefcase